American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM–IV). APA.
Amsden, G. W. & Georgian, F. (1996) Orthostatic hypotension induced by sertraline withdrawal. Pharmacotherapy, 16, 684–686.
Andersen, H. & Kristiansen, E. S. (1959) Tofranil treatment of endogenous depressions. Acta Psychiatrica Scandinavica, 34, 387–397.
Anderson, I. M., Nutt, D. J. & Deakin, J.F. (2000) Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. Journal of Psychopharmacology, 14, 3–20.
Baldwin, D. S., Montgomery, S. A., Nil, R.
et al (2007) Discontinuation symptoms in depression and anxiety disorders. International Journal of Neuropsychopharmacology, 10, 73–84.
Benazzi, F. (1996) Venlafaxine withdrawal symptoms. Canadian Journal of Psychiatry, 41, 487.
Benazzi, F. (1999) Selective serotonin reuptake inhibitor discontinuation syndrome: putative mechanisms and prevention strategies. Canadian Journal of Psychiatry, 44, 95–96.
Black, K., Shea, C., Dursun, S.
et al (2000) Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria. Journal of Psychiatry and Neuroscience, 25, 255–261.
Bloch, M., Stager, S. V., Braun, A. R.
et al (1995) Severe psychiatric symptoms associated with paroxetine withdrawal. Lancet, 346, 57.
Bogetto, F., Bellino, S., Revello, R. B.
et al (2002) Discontinuation syndrome in dysthymic patients treated with selective serotonin reuptake inhibitors: a clinical investigation. CNS Drugs, 16, 273–283.
British Medical Association & Royal Pharmaceutical Society of Great Britain (2007) British National Formulary (March issue). BMJ Publishing Group & RPS Publishing.
Cowe, L., Lloyd, D. J. & Dawling, S. (1982) Neonatal convulsions caused by withdrawal from maternal clomipramine. BMJ (Clinical Research Edition), 19, 1837–1838.
Demyttenaere, K., Mesters, P., Boulanger, B.
et al (2001) Adherence to treatment regimen in depressed patients treated with amitriptyline or fluoxetine. Journal of Affective Disorders, 65, 243–252.
Dilsaver, S. C., Kronfol, Z., Greden, J. F.
et al (1983a) Antidepressant withdrawal syndromes: evidence supporting the cholinergic overdrive hypothesis. Journal of Clinical Psychopharmacology, 3, 157–164.
Dilsaver, S. C., Feinberg, M. & Greden, J. F. (1983b) Antidepressant withdrawal symptoms treated with anticholinergic agents. American Journal of Psychiatry, 140, 249–251.
Dominguez, R. A. & Goodnick, P. J. (1995) Adverse events after the abrupt discontinuation of paroxetine. Pharmacotherapy, 15, 778–780.
Donoghue, J. & Haddad, P. (1999) Pharmacists lack knowledge of antidepressant discontinuation symptoms. Journal of Clinical Psychiatry, 60, 124–125.
Drug and Therapeutics Bulletin (1999) Withdrawing patients from antidepressants. Drug and Therapeutics Bulletin, 37 (July), 49–52.
Einbinder, E. (1995) Fluoxetine withdrawal?
American Journal of Psychiatry, 152, 1253.
Fava, M., Mulroy, R., Alpert, J.
et al (1997) Emergence of adverse effects following discontinuation of treatment with extended-release venlafaxine. American Journal of Psychiatry, 154, 1760–1762.
Frost, L. & Lal, S. (1995) Shock-like sensations after discontinuation of selective serotonin reuptake inhibitors. American Journal of Psychiatry, 152, 810.
Giakas, W. J. & Davis, S. M. (1997) Intractable withdrawal from venlafaxine treated with fluoxetine. Psychiatric Annals, 27, 85–86.
Goldstein, T. R., Frye, M. A., Denicoff, K. D.
et al (1999) Antidepressant discontinuation-related mania: critical prospective observation and theoretical implications in bipolar disorder. Journal of Clinical Psychiatry, 60, 563–67
Haddad, P. (1998) The SSRI discontinuation syndrome. Journal of Psychopharmacology, 12, 305–313.
Haddad, P. (1999) Do antidepressants have any potential to cause addiction?
Journal of Pychopharmacology, 13, 300–307.
Haddad, P. M. (2005) Do antidepressants cause dependence?
Epidemiologia e Psichiatria Sociale, 14(2), 58–62.
Haddad, P. & Anderson, I. (1999) Antidepressants aren't addictive: clinicians have depended on them for years. Journal of Psychopharmacology, 13, 291–292.
Haddad, P. M. & Qureshi, M. (2000) Misdiagnosis of antidepressant discontinuation symptoms. Acta Psychiatrica Scandinavica, 102, 466–468.
Haddad, P., Tylee, A. & Young, A. P. (1999) General practitioners' knowledge of antidepressant discontinuation reactions (abstract). Journal of Psychopharmacology, 13 (suppl. A.), A44.
Haddad, P. M., Devarajan, S. & Dursun, S. M. (2001) Antidepressant discontinuation symptoms presenting as ‘stroke’. Journal of Psychopharmacology, 15, 139–141.
Haddad, P. M., Pal, B. R., Clarke, P.
et al (2005) Neonatal symptoms following maternal paroxetine treatment: serotonin toxicity or paroxetine discontinuation syndrome?
Journal of Psychopharmacology, 19, 554–557.
Halle, M. T. & Dilsaver, S. C. (1993) Tranylcypromine withdrawal phenomena. Journal of Psychiatry and Neuroscience, 18, 49–50.
Hirose, S. (2001) Restlessness related to SSRI withdrawal. Psychiatry and Clinical Neurosciences, 55, 79–80.
Judge, R., Parry, M. G., Quail, D.
et al (2002) Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment. International Clinical Psychopharmacology, 17, 217–225.
Kent, L. S. W. & Laidlaw, J. D. D. (1995) Suspected congenital sertraline dependence. British Journal of Psychiatry, 167, 412–413.
Keuthen, N. J., Cyr, P., Ricciardi, J. A.
et al (1994) Medication withdrawal symptoms in obsessive–compulsive disorder patients treated with paroxetine. Journal of Clinical Psychopharmacology, 14, 206–207.
Koopowitz, L. F. & Berk, M. (1995) Paroxetine induced withdrawal effects. Human Psychopharmacology, 10, 147–148.
Kramer, J. C., Klein, D. F. & Fink, M. (1961) Withdrawal symptoms following discontinuation of imipramine therapy. American Journal of Psychiatry, 118, 549–550.
Laine, K., Heikkinen, T., Ekblad, U.
et al (2003) Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Archives of General Psychiatry, 60, 720–726.
Liskin, B., Roose, S. & Walsh, T. (1984) Acute psychosis following phenelzine discontinuation. Journal of Clinical Psychopharmacology, 5, 46–47.
Louie, A. K., Lannon, R. A., Kirsch, M. A.
et al (1996) Venlafaxine withdrawal reactions. American Journal of Psychiatry, 153, 1652.
MacCall, C. & Callender, J. (1999) Mirtazapine withdrawal causing hypomania. British Journal of Psychiatry, 175, 390.
Mann, A. M. & MacPherson, A. (1959) Clinical experience with imipramine (G22355) in the treatment of depression. Canadian Psychiatric Association Journal, 4, 38–47.
Medawar, C. (1997) The antidepressant web – marketing depression and making medicines work. International Journal of Risk and Safety in Medicine, 10, 75–126.
Michelson, D., Fava, M., Amsterdam, J.
et al (2000) Interruption of selective serotonin reuptake inhibitor treatment. Double-blind, placebo-controlled trial. British Journal of Psychiatry, 176, 363–368.
Mirin, S. M., Schatzberg, A. F. & Creasey, D. E. (1981) Hypomania and mania after withdrawal of tricyclic antidepressants. American Journal of Psychiatry, 138, 87–89.
Nelson, J. C., Schottenfeld, R. S. & Conrad, E. D. (1983) Hypomania after desipramine withdrawal. American Journal of Psychiatry, 140, 624–625.
Pacheco, L., Malo, P., Aragues, E.
et al (1996) More cases of paroxetine withdrawal syndrome. British Journal of Psychiatry, 169, 384.
Perahia, D. G., Kajdasz, D. K., Desaiah, D.
et al (2005) Symptoms following abrupt discontinuation of duloxetine treatment in patients with major depressive disorder. Journal of Affective Disorders, 89, 207–212.
Phillips, S. D. (1995) A possible paroxetine withdrawal syndrome. American Journal of Psychiatry, 152, 645–646.
Price, J. S., Waller, P. C., Wood, S. M.
et al (1996) A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors, including the investigation of symptoms occurring on withdrawal. British Journal of Clinical Pharmacology, 42, 757–763.
Rosenbaum, J. F., Fava, M., Hoog, S. L.
et al (1998) Selective serotonin reuptake inhibitor discontinuation syndrome: a randomised clinical trial. Biological Psychiatry, 44, 77–87.
Roth, S. D. (1985) More on psychosis following phenelzine discontinuation. Journal of Clinical Psychopharmacology, 5, 360–361.
Rothschild, A. J. (1985) Mania after withdrawal of isocarboxazid. Journal of Clinical Psychopharmacology, 5, 340–342.
Rush, A. J., Trivedi, M. H., Wisniewski, S. R.
et al (2006) Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. New England Journal of Medicine, 354, 1231–1242.
Sathananthan, G. L. & Gershon, S. (1973) Imipramine withdrawal: an akathisia-like syndrome. American Journal of Psychiatry, 130, 1286–87
Schatzberg, A. F., Haddad, P., Kaplan, E. M.
et al (1997) Possible biological mechanisms of the serotonin reuptake inhibitor discontinuation syndrome. Journal of Clinical Psychiatry, 58 (suppl. 7), 23–27.
Schatzberg, A. F., Blier, P., Delgado, P. L.
et al (2006) Antidepressant discontinuation syndrome: consensus panel recommendations for clinical management and additional research. Journal of Clinical Psychiatry, 67 (suppl 4), 27–30.
Stoukides, J. A. & Stoukides, C. A. (1991) Extrapyramidal symptoms upon discontinuation of fluoxetine. American Journal of Psychiatry, 148, 1263.
Szabadi, E. (1992) Fluvoxamine withdrawal syndrome. British Journal of Psychiatry, 160, 283–284.
Tint, A., Haddad, P. M. & Anderson, I. M. (2007) The effect of rate of antidepressant tapering on the incidence of discontinuation symptoms: a randomised study. Journal of Psychopharmacology, in press.
Tyrer, P. (1984) Clinical effects of abrupt withdrawal from tricyclic antidepressants and monoamine oxidase inhibitors after long term treatment. Journal of Affective Disorders, 6, 1–7.
Tyrer, P. (1999) Stress diathesis and pharmacological dependence. Journal of Psychopharmacology, 13, 294–295.
Vandel, P., Sechter, D., Weiller, E.
et al (2004) Post-treatment emergent adverse events in depressed patients following treatment with milnacipran and paroxetine. Human Psychopharmacology, 19, 585–586.
Wolfe, R. M. (1997) Antidepressant withdrawal reactions. American Family Physician, 56, 452–462.
World Health Organization (1992) The ICD–10 Classification of Mental and Behavioural Disorders. World Health Organization.
Young, A. H. & Currie, A. (1997) Physicians' knowledge of antidepressant withdrawal effects: a survey. Journal of Clinical Psychiatry, 58 (suppl. 7), 28–30.